Jui-Feng Hsu

423 total citations
15 papers, 318 citations indexed

About

Jui-Feng Hsu is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Jui-Feng Hsu has authored 15 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Jui-Feng Hsu's work include Circadian rhythm and melatonin (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Retinoids in leukemia and cellular processes (2 papers). Jui-Feng Hsu is often cited by papers focused on Circadian rhythm and melatonin (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Retinoids in leukemia and cellular processes (2 papers). Jui-Feng Hsu collaborates with scholars based in Taiwan. Jui-Feng Hsu's co-authors include Yi‐Chang Liu, Ming‐Yu Yang, Pai‐Mei Lin, Hui‐Hua Hsiao, Chih‐Jen Yang, Wen‐Chi Yang, Sheng‐Fung Lin, Hsuan‐Fu Kuo, Shang‐Yi Lin and Cheng‐Ming Hsu and has published in prestigious journals such as Blood, PLoS ONE and BMC Cancer.

In The Last Decade

Jui-Feng Hsu

15 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jui-Feng Hsu Taiwan	9	92	80	78	72	67	15	318
R Johnson United States	5	89 1.0×	51 0.6×	43 0.6×	10 0.1×	102 1.5×	5	347
Ruiqi Li China	10	57 0.6×	56 0.7×	25 0.3×	5 0.1×	96 1.4×	26	375
Miriam Sánchez Spain	10	40 0.4×	97 1.2×	70 0.9×	29 0.4×	24 0.4×	16	296
Giuseppina Martino Italy	11	97 1.1×	43 0.5×	10 0.1×	35 0.5×	19 0.3×	21	305
Bharati Kadamb Patel Singapore	8	36 0.4×	45 0.6×	14 0.2×	61 0.8×	42 0.6×	12	238
Carine Raquel Richter Schmitz Brazil	5	86 0.9×	81 1.0×	16 0.2×	7 0.1×	31 0.5×	5	303
Kaifang Zou China	11	85 0.9×	39 0.5×	16 0.2×	46 0.6×	40 0.6×	24	377
Jarna Moilanen Finland	8	47 0.5×	31 0.4×	20 0.3×	45 0.6×	18 0.3×	10	334
Caili Li China	10	44 0.5×	20 0.3×	60 0.8×	14 0.2×	76 1.1×	44	209

Countries citing papers authored by Jui-Feng Hsu

Since Specialization

Citations

This map shows the geographic impact of Jui-Feng Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jui-Feng Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jui-Feng Hsu more than expected).

Fields of papers citing papers by Jui-Feng Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jui-Feng Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jui-Feng Hsu. The network helps show where Jui-Feng Hsu may publish in the future.

Co-authorship network of co-authors of Jui-Feng Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Jui-Feng Hsu. A scholar is included among the top collaborators of Jui-Feng Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jui-Feng Hsu. Jui-Feng Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Chuang, Hsiang-Hao, Jui-Feng Hsu, Pei‐Hui Wang, et al.. (2020). Pin1 coordinates HDAC6 upregulation with cell migration in lung cancer cells. International Journal of Medical Sciences. 17(17). 2635–2643. 5 indexed citations

Hung, Chi‐Chih, Yen‐Yi Zhen, Sheng‐Wen Niu, et al.. (2020). Lung Cancer Cell-Derived Secretome Mediates Paraneoplastic Inflammation and Fibrosis in Kidney in Mice. Cancers. 12(12). 3561–3561. 10 indexed citations

Yang, Chih‐Jen, Ming‐Ju Tsai, Jen‐Yu Hung, et al.. (2017). The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon 19 or exon 21 mutations. BMC Pharmacology and Toxicology. 18(1). 82–82. 32 indexed citations

Hsu, Jui-Feng, et al.. (2016). Acute respiratory distress syndrome and acute myocarditis developed in a previously healthy adult with influenza B. BMC Pulmonary Medicine. 16(1). 1–1. 59 indexed citations

Yang, Ming‐Yu, Pai‐Mei Lin, Hui‐Hua Hsiao, et al.. (2015). Up-regulation of PER3 Expression Is Correlated with Better Clinical Outcome in Acute Leukemia.. PubMed. 35(12). 6615–22. 22 indexed citations

Hsu, Jui-Feng, et al.. (2015). Port type is a possible risk factor for implantable venous access port-related bloodstream infections and no sign of local infection predicts the growth of gram-negative bacilli. World Journal of Surgical Oncology. 13(1). 288–288. 13 indexed citations

Wei, Sung‐Hsi, Tsai-Hung Wu, Jui-Feng Hsu, et al.. (2013). Legionnaires’ disease caused by Legionella longbeachae in Taiwan, 2006–2010. International Journal of Infectious Diseases. 19. 95–97. 8 indexed citations

Liu, Yi‐Chang, Hui‐Hua Hsiao, Chao-Sung Chang, et al.. (2013). Outcome of allotransplants in patients with chronic-phase chronic myeloid leukemia following imatinib failure: prognosis revisited.. PubMed. 33(10). 4663–7. 2 indexed citations

Yang, Wen‐Chi, Pai‐Mei Lin, Ming‐Yu Yang, et al.. (2012). Higherlipocalin 2expression may represent an independent favorable prognostic factor in cytogenetically normal acute myeloid leukemia. Leukemia & lymphoma. 54(8). 1614–1625. 17 indexed citations

10.

Liu, Yi‐Chang, Yi‐Hsin Yang, Hui‐Hua Hsiao, et al.. (2012). Herpes zoster is associated with an increased risk of subsequent lymphoid malignancies - A nationwide population-based matched-control study in Taiwan. BMC Cancer. 12(1). 503–503. 20 indexed citations

11.

Yang, Ming‐Yu, Pai‐Mei Lin, Yi‐Chang Liu, et al.. (2012). Induction of Cellular Senescence by Doxorubicin Is Associated with Upregulated miR-375 and Induction of Autophagy in K562 Cells. PLoS ONE. 7(5). e37205–e37205. 63 indexed citations

12.

Liu, Yi‐Chang, et al.. (2011). JAK2V617Fmutation is associated with special alleles in essential thrombocythemia. Leukemia & lymphoma. 52(3). 478–482. 3 indexed citations

13.

Yang, Ming‐Yu, Wen‐Chi Yang, Pai‐Mei Lin, et al.. (2011). Altered Expression of Circadian Clock Genes in Human Chronic Myeloid Leukemia. Journal of Biological Rhythms. 26(2). 136–148. 62 indexed citations

14.

Yang, Ming‐Yu, Jan‐Gowth Chang, Pai‐Mei Lin, et al.. (2011). Altered Regulation of Imprinted Non-Coding RNA Genes in Acute Myeloid Leukemia,. Blood. 118(21). 3456–3456. 1 indexed citations

15.

Yang, Ming‐Yu, Wen‐Chi Yang, Pai‐Mei Lin, et al.. (2010). Induction of Senescence by Doxorubicin Is Associated with Upregulated Mir-375 and Induction of Autophagy In CML Cell Line K562. Blood. 116(21). 1843–1843. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact